Gf Fund Management Co. Ltd. Veracyte, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,627 shares of VCYT stock, worth $63,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,627Holding current value
$63,745% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
337Shares Held
80.2MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$322 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$305 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$259 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$165 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$160 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.8B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...